We continue to hear from Rejuvenate and ABG II hip stem recipients who have allegedly suffered injuries related to the Stryker hip recall. We are looking forward to additional progress in this litigation in the New Year.
New York, New York (PRWEB) January 02, 2014
Hundreds of Stryker hip lawsuits (http://www.strykerhiprecallclaims.com/ ) filed on behalf of patients who were allegedly injured by Rejuvenate and ABG II Modular-Neck Hip Stems are continuing to move forward in New Jersey’s Bergen County Superior Court, Bernstein Liebhard LLP reports. According to court documents, the proceeding’s first Case Management Conference of 2014 has been scheduled for January 28th at 11:00 a.m. As of December 24, 2013, at least 600 product liability claims related to the 2012 Stryker hip recall for Rejuvenate and ABG II hip stems were pending in the New Jersey multicounty litigation. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)
“We continue to hear from Rejuvenate and ABG II hip stem recipients who have allegedly suffered injuries related to the Stryker hip recall. We are looking forward to additional progress in this litigation in the New Year,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who have suffered serious complications, allegedly related to the Stryker recall for Rejuvenate and ABG II hip stems.
Stryker Hip Recall
Stryker announced the Rejuvenate and ABG II hip stem recall in July 2012, after post-market data indicated the metal components were prone to fretting and corrosion at the modular neck junction, placing recipients at risk for pain, swelling, adverse local tissue reactions, and premature failure of their hip implant. All patients fitted with Rejuvenate and ABG II hip stems have been advised by Stryker to undergo imaging and blood tests to ensure their hips are functioning properly, even in the absence of symptoms. Some asymptomatic patients have nevertheless suffered adverse local tissue reactions and elevated levels of metal ions in their blood, according to the company.*
According to court documents, a program for early mediation of some Stryker hip lawsuits is now underway in Bergen County Superior Court. Already, Phase I of early mediation has resulted in four Stryker hip settlements. Ten cases were selected for the Phase I mediation, and mediation efforts will begin this month in four of those remaining lawsuits. The parties were unable to reach resolution in the two final cases chosen for the first phase of early mediation. Court records indicate that Phase II of early mediation is about to get underway, and the parties have been directed to select 42 cases for the early mediation pool no later than January 10, 2013.
A multidistrict litigation for federal product liability claims related to the Stryker hip recall has also been established in U.S. District Court, District of Minnesota, where at lease 462 lawsuits are pending thus far. Like those filed in the New Jersey proceeding, these claims allege that Rejuvenate and ABG II hip stems can shed dangerous amounts of metal ions into recipients’ tissue and blood stream, resulting in metallosis, adverse local tissue reactions, necrosis, osteolysis, and failure of the hip. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL No. 2441)
Individuals who have allegedly been injured by Rejuvenate and ABG II hip stems could be eligible for compensation for their injury-related damages, including medical bills, lost income, pain and suffering, and more. To learn more about filing a Stryker hip lawsuit, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to arrange for a free, no-obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP